Precigen
PGEN
138 hedge funds and large institutions have $66M invested in Precigen in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 33 increasing their positions, 46 reducing their positions, and 30 closing their positions.
11% more call options, than puts
Call options by funds: $111K | Put options by funds: $100K
1% more capital invested
Capital invested by funds: $65.1M → $66M (+$904K)
1.91% less ownership
Funds ownership: 24.37% → 22.46% (-1.9%)
12% less funds holding
Funds holding: 157 → 138 (-19)
28% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 46
63% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Patient Capital Management
Baltimore,
Maryland
|
+$11.5M |
| 2 |
BlackRock
New York
|
+$926K |
| 3 |
State Street
Boston,
Massachusetts
|
+$442K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$282K |
| 5 |
CAM
ClariVest Asset Management
San Diego,
California
|
+$236K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$10.1M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$1.32M |
| 3 |
Renaissance Technologies
New York
|
-$835K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$780K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$646K |
PGEN Hedge Fund Activity: Q2 2023 in Review
138 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q2 2023, worth a combined $66M — up 1.4% from $65.1M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of PGEN and 11 opened new positions — a net loss of 19 holders — while 46 trimmed existing stakes and 33 added.
The largest buyer was Patient Capital Management, adding an estimated $11.5M. The largest seller was Miller Value Partners, exiting entirely with an estimated $10.1M sold.
- 138 institutional investors held Precigen (PGEN) as of Q2 2023, down from 157 in Q1 2023.
- Funds reported $66M of Precigen stock for Q2 2023, up 1.4% quarter-over-quarter.
- 11 funds opened new Precigen positions in Q2 2023 and 30 closed out, a net change of -19 holders.
- The largest Precigen buyer in Q2 2023 was Patient Capital Management, an estimated $11.5M added.
- The largest Precigen seller in Q2 2023 was Miller Value Partners, an estimated $10.1M sold.
Based on aggregated 13F filings for Q2 2023.